ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money.

March 18, 2005

White House Says Upton Appointment Due In Two Weeks

July 29, 1977

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004

New Report On Survival Data Available From NCI

July 25, 1975

October issue of Business & Regulatory Report included.

November 5, 2004